SCHIATTARELLA, GABRIELE GIACOMO
 Distribuzione geografica
Continente #
AS - Asia 4.034
NA - Nord America 3.016
EU - Europa 2.448
SA - Sud America 486
AF - Africa 101
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 1
Totale 10.097
Nazione #
US - Stati Uniti d'America 2.899
SG - Singapore 1.738
RU - Federazione Russa 1.102
CN - Cina 870
VN - Vietnam 640
IT - Italia 522
BR - Brasile 385
HK - Hong Kong 345
DE - Germania 163
FR - Francia 149
NL - Olanda 126
JP - Giappone 102
FI - Finlandia 78
GB - Regno Unito 74
CA - Canada 72
BD - Bangladesh 64
IE - Irlanda 50
IN - India 50
KR - Corea 46
AR - Argentina 40
SE - Svezia 38
ZA - Sudafrica 29
CI - Costa d'Avorio 28
MX - Messico 27
PL - Polonia 26
AT - Austria 22
TR - Turchia 22
IQ - Iraq 21
ID - Indonesia 20
EC - Ecuador 19
PH - Filippine 18
ES - Italia 17
TW - Taiwan 16
TH - Thailandia 14
LT - Lituania 12
PK - Pakistan 12
PY - Paraguay 11
UA - Ucraina 11
CO - Colombia 10
MY - Malesia 10
BE - Belgio 9
CZ - Repubblica Ceca 8
VE - Venezuela 7
CL - Cile 6
KE - Kenya 6
AZ - Azerbaigian 5
EG - Egitto 5
IL - Israele 5
MA - Marocco 5
NP - Nepal 5
NZ - Nuova Zelanda 5
TN - Tunisia 5
UY - Uruguay 5
AE - Emirati Arabi Uniti 4
AM - Armenia 4
AU - Australia 4
CH - Svizzera 4
DO - Repubblica Dominicana 4
RO - Romania 4
SN - Senegal 4
UZ - Uzbekistan 4
CG - Congo 3
GR - Grecia 3
JO - Giordania 3
KG - Kirghizistan 3
PE - Perù 3
PT - Portogallo 3
RS - Serbia 3
SA - Arabia Saudita 3
TZ - Tanzania 3
AD - Andorra 2
AL - Albania 2
CR - Costa Rica 2
DK - Danimarca 2
DZ - Algeria 2
EE - Estonia 2
HN - Honduras 2
KZ - Kazakistan 2
LV - Lettonia 2
MD - Moldavia 2
NO - Norvegia 2
PA - Panama 2
PS - Palestinian Territory 2
SK - Slovacchia (Repubblica Slovacca) 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BY - Bielorussia 1
CD - Congo 1
CU - Cuba 1
CV - Capo Verde 1
CW - ???statistics.table.value.countryCode.CW??? 1
DJ - Gibuti 1
DM - Dominica 1
HT - Haiti 1
IR - Iran 1
IS - Islanda 1
JM - Giamaica 1
KH - Cambogia 1
KN - Saint Kitts e Nevis 1
Totale 10.077
Città #
Singapore 848
San Jose 560
Hong Kong 334
Ashburn 284
Moscow 282
Beijing 248
Hefei 228
Chandler 198
Ho Chi Minh City 177
Hanoi 141
Amsterdam 108
Los Angeles 96
New York 95
Tokyo 91
Lauterbourg 84
Santa Clara 77
Napoli 76
The Dalles 75
Naples 67
Millbury 58
Munich 57
Boston 54
Princeton 48
Redondo Beach 44
Buffalo 43
Nanjing 43
São Paulo 43
Dong Ket 40
Seoul 40
Des Moines 36
Council Bluffs 31
Frankfurt am Main 29
Haiphong 27
Ottawa 27
Da Nang 25
Orem 25
Atlanta 22
Rome 22
Rio de Janeiro 21
Helsinki 19
Montreal 19
Stockholm 18
Brooklyn 17
Dallas 17
Warsaw 17
Wilmington 17
Chicago 16
Nuremberg 16
Turku 16
Denver 14
London 14
Tianjin 14
Lawrence 13
Nanchang 13
Phoenix 13
San Francisco 12
Ankara 11
Toronto 11
Washington 11
Redwood City 10
Shanghai 10
Shenyang 10
Biên Hòa 9
Chennai 9
Fairfield 9
Guangzhou 9
Hsinchu 9
Johannesburg 9
Hebei 8
Seattle 8
Brussels 7
Buenos Aires 7
Hải Dương 7
Jakarta 7
Mexico City 7
Newark 7
Turin 7
Asunción 6
Augusta 6
Baghdad 6
Berlin 6
Can Tho 6
Cape Town 6
Curitiba 6
Houston 6
Jacksonville 6
Jiaxing 6
Kuala Lumpur 6
Kunming 6
Manchester 6
Milan 6
Mumbai 6
Poplar 6
Quito 6
Vienna 6
Afragola 5
Bangkok 5
Borghetto Santo Spirito 5
Brno 5
Changsha 5
Totale 5.384
Nome #
Akap1 deficiency promotes mitochondrial aberrations and exacerbates cardiac injury following permanent coronary ligation via enhanced mitophagy and apoptosis 221
Epigenetic Switch at Atp2a2 and Myh7 Gene Promoters in Pressure Overload-Induced Heart Failure 188
Akap1 Regulates Vascular Function and Endothelial Cells Behavior 183
Correction: Akap1 deficiency promotes mitochondrial aberrations and exacerbates cardiac injury following permanent coronary ligation via enhanced mitophagy and apoptosis 176
EGFR activation triggers cellular hypertrophy and lysosomal disease in NAGLU-depleted cardiomyoblasts, mimicking the hallmarks of mucopolysaccharidosis IIIB 174
AKAP121 downregulation impairs protective cAMP signals, promotes mitochondrial dysfunction, and increases oxidative stress. 162
Dermcidin: a skeletal muscle myokine modulating cardiomyocyte survival and infarct size after coronary artery ligation 162
Moderate to severe mitral regurgitation in patients undergoing trancatheter aortic valve replacement: a meta-analysis of mortality outcomes and mitral regurgitation evolution in 4,933 patients 161
Transverse aortic constriction induces gut barrier alterations, microbiota remodeling and systemic inflammation [*Boccella N., Paolillo R. and Coretti L. co-first authors] 161
Loss of Akap1 exacerbates pressure overload-induced cardiac hypertrophy and heart failure 156
High-resolution DNA methylation changes reveal biomarkers of heart failure with preserved ejection fraction versus reduced ejection fraction 154
The Murine Model of Mucopolysaccharidosis IIIB Develops Cardiopathies over Time Leading to Heart Failure 154
Effects of a New Combination of Nutraceuticals with Morus alba on Lipid Profile, Insulin Sensitivity and Endotelial Function in Dyslipidemic Subjects. A Cross-Over, Randomized, Double-Blind Trial. 142
Abdominal aortic aneurysm in patients affected by intermittent claudication: Prevalence and clinical predictors 142
The role of mitochondrial dynamics in cardiovascular diseases 141
IDENTIFICAZIONE PROTEOMICA DI UN NUOVO FATTORE COINVOLTO NELLA MODULAZIONE MOLECOLARE DEL RIMODELLAMENTO CARDIACO POST-ISCHEMICO NELL'ISCHEMIA CRONICA DEGLI ARTI INFERIORI. 140
Low-dose quinacrine reduces vascular restenosis without affecting re-endothelialization 137
Immunometabolic Mechanisms of Heart Failure with Preserved Ejection Fraction 137
Impact of chronic kidney disease on platelet aggregation in patients with acute coronary syndrome 136
Quinacrine as a Novel Anti-Restenotic and Anti-Thrombotic Drug for Coronary Artery Interventions. 136
Mitochondrial a Kinase Anchor Proteins in Cardiovascular Health and Disease: A Review Article on Behalf of the Working Group on Cellular and Molecular Biology of the Heart of the Italian Society of Cardiology 135
Effects of Carvedilol Versus Metoprolol on Platelet Aggregation in Patients With Acute Coronary Syndrome: The PLATE-BLOCK Study 135
Statins and the elderly: Recent evidence and current indications 133
A roadmap for therapeutic discovery in pulmonary hypertension associated with left heart failure. A scientific statement of the Heart Failure Association (HFA) of the ESC and the ESC Working Group on Pulmonary Circulation & Right Ventricular Function 130
Cardiac metabolism in HFpEF: from fuel to signalling 129
Immunoglobulins G modulate endothelial function and affect insulin sensitivity in humans 129
Genetic deletion in uncoupling protein 3 augments 18F-fluorodeoxyglucose cardiac uptake in the ischemic heart 127
Cerebral embolic lesions detected with diffusion-weighted magnetic resonance imaging following carotid artery stenting: a meta-analysis of 8 studies comparing filter cerebral protection and proximal balloon occlusion. 126
Prevalence and characteristics of true and apparent treatment resistant hypertension in the Campania Salute Network. 126
Rac-1 as a new target to modulate endothelial function and platelet aggregation in diabetes mellitus 126
Meta-Analysis of Mortality Outcomes and Mitral Regurgitation Evolution in 4,839 Patients Having Transcatheter Aortic Valve Implantation for Severe Aortic Stenosis. 125
Novel Molecular Approaches in Heart Failure: Seven Trans-Membrane Receptors Signaling in the Heart and Circulating Blood Leukocytes 125
ATHERECTOMY AS ALTERNATIVE ENDOVASCULAR THERAPY FOR INFRAINGUINAL ARTERY DISEASE. 123
Cardiac Side Effects of Chemotherapy: State of Art and Strategies for a Correct Management. 123
Use of statins in lower extremity artery disease: a review 121
Increased mortality after transcatheter aortic valve implantation (TAVI) in patients with severe aortic stenosis and low ejection fraction: A meta-analysis of 6898 patients 118
Contemporary use and results of intra-aortic balloon pump counterpulsation. 113
Meta-Analysis of Effect of Body Mass Index on Outcomes After Transcatheter Aortic Valve Implantation 113
A meta-analysis of the impact of pre-existing and new-onset atrial fibrillation on clinical outcomes in patients undergoing transcatheter aortic valve implantation 110
How to facilitate seamless translation from basic concepts to new heart failure drugs. A scientific statement of the Heart Failure Association of the ESC 108
AngioJet rheolytic thrombectomy for acute superficial femoral artery stent or femoropopliteal by-pass thrombosis 108
Novel basic science insights to improve the management of heart failure: Review of the working group on cellular and molecular biology of the heart of the italian society of cardiology 108
The pitfalls of managing thrombosis of an Absorb?-treated bifurcation 107
Physical activity in the prevention of peripheral artery disease in the elderly 107
Fibroblast Primary Cilia Are Required for Cardiac Fibrosis 104
Distinctive patterns of inflammation across the heart failure syndrome 103
Gut microbe-generated metabolite trimethylamine-N-oxide as cardiovascular risk biomarker: a systematic review and dose-response meta-analysis 102
A collagen membrane-based engineered heart tissue improves cardiac function in ischemic rat hearts 99
Cardiovascular effects of histone deacetylase inhibitors epigenetic therapies: Systematic review of 62 studies and new hypotheses for future research 98
Genetic deletion of uncoupling protein 3 exaggerates apoptotic cell death in the ischemic heart leading to heart failure 95
Comparison of Baseline Characteristics and Outcomes in Men Versus Women With Aortic Stenosis Undergoing Transcatheter Aortic Valve Implantation 82
Unexpected preserved brain perfusion imaging despite severe and diffuse atherosclerosis of supra-aortic trunks : case report - online article 81
Diagnostics and therapeutic implications of gut microbiota alterations in cardiometabolic diseases 80
Feeding Diastolic Dysfunction: Is It a Bug? 80
Epigenetic Reader BRD4 (Bromodomain-Containing Protein 4) Governs Nucleus-Encoded Mitochondrial Transcriptome to Regulate Cardiac Function 80
Lysozyme 1 Inflamed CCR2+ Macrophages Promote Obesity-Induced Cardiac Dysfunction 79
Survival and Cardiovascular Outcomes of Patients With Secondary Mitral Regurgitation: A Systematic Review and Meta-analysis 79
NAD+Repletion Reverses Heart Failure with Preserved Ejection Fraction 76
Long COVID and the cardiovascular system - elucidating causes and cellular mechanisms in order to develop targeted diagnostic and therapeutic strategies: A joint Scientific Statement of the ESC Working Groups on Cellular Biology of the Heart and Myocardial & Pericardial Diseases 75
Double layered stents for carotid angioplasty: A meta-analysis of available clinical data 75
Xbp1s-FoxO1 axis governs lipid accumulation and contractile performance in heart failure with preserved ejection fraction 75
Nuovi concetti nella segnalazione beta-adrenergica: prospettive terapeutiche per lo scompenso cardiaco.. [Novel concepts in beta-adrenergic receptor signaling: therapeutic options for heart failure]. 73
Tackling metabolic defects in HFpEF 71
The Lure of Cardiac Metabolism in the Diagnosis, Prevention, and Treatment of Heart Failure 71
Opportunities and challenges for the use of human samples in translational cardiovascular research. A Scientific Statement of the ESC Working Group on Cellular Biology of the Heart, the ESC Working Group on Cardiovascular Surgery, the ESC Council on Basic Cardiovascular Science, the ESC Scientists of Tomorrow, the European Association of Percutaneous Cardiovascular Interventions of the ESC and the Heart Failure Association of the ESC 71
Activation of Autophagic Flux Blunts Cardiac Ischemia/Reperfusion Injury 71
Heart failure with preserved ejection fraction in humans and mice: Embracing clinical complexity in mouse models 71
Canagliflozin and myocardial oxidative stress: SGLT1 inhibition takes centre stage 70
Rac 1 modulates endothelial function and platelet aggregation in diabetes mellitus 70
Nitrosative stress drives heart failure with preserved ejection fraction 70
Implications of SGLT Inhibition on Redox Signalling in Atrial Fibrillation 69
Metabolic remodelling in atrial fibrillation: manifestations, mechanisms and clinical implications 67
Lifestyle interventions in cardiometabolic HFpEF: dietary and exercise modalities 67
Perivascular fibrosis and the microvasculature of the heart. Still hidden secrets of pathophysiology? 66
Can hfpef and hfref coexist? 66
Cooperative Binding of ETS2 and NFAT Links Erk1/2 and Calcineurin Signaling in the Pathogenesis of Cardiac Hypertrophy 65
MIR-21 ANTAGONISM IMPROVES LEFT VENTRICULAR REMODELLING AND FUNCTION AFTER MYOCARDIAL INFARCTION IN MICE. 65
The crosstalk between immune activation and metabolism in heart failure. A scientific statement of the Heart Failure Association of the ESC 64
Inflammation in aortic stenosis: Shaping the biomarkers network 64
Comments on the myPACE Randomized Clinical Trial 63
Molecular mechanisms underlying the beneficial effects of exercise and dietary interventions in the prevention of cardiometabolic diseases 63
RUOLO PROTETTIVO DELL'UNCOUPLING PROTEIN 3 (UCP3) NELLA MALATTIA ISCHEMICA. 63
Pre-existing and new-onset atrial fibrillation: a meta-analysis of mortality outcomes and cerebrovascular events in 13,795 patients undergoing transcatheter aortic valve implantation 63
The evolving landscape of cardiometabolic diseases 62
SAFETY AND EFFICACY OF OUBACK CATHETER-ASSISTED SUBINTIMAL RECANALIZATION OF TOTAL CHRONIC ILIAC ARTERY OCCLUSION. 62
Metabolic inflammation in heart failure with preserved ejection fraction 62
Impaired T cell IRE1α/XBP1 signaling directs inflammation in experimental heart failure with preserved ejection fraction 61
Impaired AMP-Activated Protein Kinase Signaling in Heart Failure With Preserved Ejection Fraction-Associated Atrial Fibrillation 61
FoxO1–Dio2 signaling axis governs cardiomyocyte thyroid hormone metabolism and hypertrophic growth 61
High-Resolution Transthoracic Echocardiography Accurately Detects Pulmonary Arterial Pressure and Decreased Right Ventricular Contractility in a Mouse Model of Pulmonary Fibrosis and Secondary Pulmonary Hypertension 61
Therapeutic targeting of autophagy in cardiovascular disease 61
Systems Biology Approach Uncovers Candidates for Liver-Heart Interorgan Crosstalk in HFpEF 60
Induction of mitogen-activated protein kinases is proportional to the amount of pressure overload. 60
Heart failure and obesity: Translational approaches and therapeutic perspectives. A scientific statement of the Heart Failure Association of the ESC 59
Targeting HFpEF: Unlocking the Potential of Glucagon Receptor Blockade 55
Remodeling of substrate consumption in the murine sTAC model of heart failure 55
Epigenetic mechanisms underlying the beneficial effects of cardiac rehabilitation. An overview from the working groups of "cellular and molecular biology of the heart" and "cardiac rehabilitation and cardiovascular prevention" of the Italian Society of Cardiology (SIC) 53
From Gut to Heart: Role of Indole-3-Propionic Acid in HFpEF 52
Microbial metabolites as predictive biomarkers: A paradigm shift for cardiovascular risk stratification 52
Polycystin-1 Assembles With Kv Channels to Govern Cardiomyocyte Repolarization and Contractility 52
Totale 10.003
Categoria #
all - tutte 31.402
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.402


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202147 0 0 0 0 0 0 0 0 0 0 0 47
2021/2022437 12 1 0 4 22 12 9 27 59 50 99 142
2022/2023563 65 33 13 27 63 64 29 57 72 100 24 16
2023/2024420 21 57 61 39 21 53 13 41 12 9 54 39
2024/20252.612 116 129 9 68 34 101 314 158 186 263 954 280
2025/20265.500 611 550 577 567 848 175 548 494 558 345 144 83
Totale 10.352